Cargando…
Multiple sclerosis and COVID‐19: How many are at risk?
BACKGROUND AND PURPOSE: The coronavirus disease 2019 (COVID‐19) pandemic challenges neurologists in counseling multiple sclerosis (MS) patients with respect to their risk for and by severe acute respiratory syndrome coronavirus 2 and in guiding disease‐modifying treatment (DMT). The objective was to...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537184/ https://www.ncbi.nlm.nih.gov/pubmed/32978860 http://dx.doi.org/10.1111/ene.14555 |